Opportunity for OM Investors in Outset Medical Securities Fraud Lawsuit Impending Storm: Outset Medical Faces Securities Fraud Lawsuit

By: Alex Freidmen

LOS ANGELES, Oct. 18, 2024
/PRNewswire/ — The Law Offices of Frank Cruz announces that investors with substantial losses have the opportunity to lead the securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) OM.

Class Period: August 1, 2022August 7, 2024
Lead Plaintiff Deadline: October 28, 2024

The complaint filed alleges
that Defendants concealed vital information from investors. These omissions included: marketing Tablo products for a use not approved by the FDA, the imminent submission of a 510(k) application for Tablo products, a risk of halting Tablo sales until receiving FDA endorsement for additional uses, a deficiency in sales resources to support Tablo sales growth, and misleading statements concerning the Company’s business and future.

To stay updated, follow us on Twitter: twitter.com/FRC_LAW.

For further details on this lawsuit, contact Frank R. Cruz at
310-914-5007 or via email at info@frankcruzlaw.com, or visit our website at www.frankcruzlaw.com.

Please be aware that this press release may be considered Attorney Advertising in some jurisdictions.

Cision
View original content to download multimedia:Source

Market News and Data brought to you by Benzinga APIs


See also  What's Going On With Nvidia Stock On Monday? - NVIDIA (NASDAQ:NVDA)